<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 2, 2000
Neogen Corporation
(Exact name of registrant as specified in its charter)
Michigan 0-17988 38-2367843
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
620 Lesher Place, Lansing, Michigan 48912
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (517) 372-9200
-----------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE> 2
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
On June 2, 2000, Neogen Corporation purchased substantially all of the assets of
AmVet Pharmaceuticals of Yaphank, New York. AmVet owns formulas for 25 different
veterinary products under approximately 40 labels, the majority of which are
sold under the AmVet name. There is no relationship between AmVet and Neogen or
any of their affiliates.
The consideration for the sale, which was determined through arms length
negotiations, subject to certain post closing adjustments, was $3,400,000, and
up to an additional $1,000,000 based on levels of post closing revenues. The
source of cash consideration was available Neogen cash balances.
Neogen intends to move the business to Lexington, Kentucky and integrate it with
its Animal Safety Division.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(a) (1) and (b) (1) Financial Statements of the business acquired and any
proforma financial statements of the business acquired will be filed within 60
days of June 16, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Neogen Corporation
(Registrant)
Date: June 16, 2000 By: s/ Richard R. Current
----------------------------
Richard R. Current
Vice President and CFO
Page 2
